Gilead Sciences Debt Repayments increased by 34475.0% to $2.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 57.0%, from $1.76B to $2.77B. Over 3 years (FY 2021 to FY 2025), Debt Repayments shows a downward trend with a -27.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease indicates lower debt service requirements, while an increase may signal a strategic effort to reduce leverage or meet debt maturity obligations.
This metric represents the total cash outflows used to reduce the principal balance of outstanding debt obligations, inc...
Standard across all capital-intensive industries; peers typically disclose this in the financing section of the cash flow statement.
financing_repayments_of_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $2.50B | $1.00B | $500.00M | $1.00B | $0.00 | $0.00 | $2.25B | $0.00 | $0.00 | $1.85B | $112.00M | $7.00M | $1.76B | $9.00M | $9.00M | $8.00M | $2.77B |
| QoQ Change | — | — | -60.0% | -50.0% | +100.0% | -100.0% | — | — | -100.0% | — | — | -93.9% | -93.8% | >999% | -99.5% | +0.0% | -11.1% | >999% |
| YoY Change | — | — | — | — | -60.0% | -100.0% | — | +125.0% | — | — | — | -95.0% | — | — | -99.5% | -92.0% | +14.3% | +57.0% |